19 Dec, 2024 Our Predictions for Life Sciences in 2025 By DLA Piper Life Sciences As the New Year is fast approaching, we asked members of our Life Sciences team to share their predictions of what will be the key issues...
07 Jun, 2024 DLA Piper Life Sciences Index 2024 By Lyndsey Hudson Marco de Morpurgo Welcome to the first edition of the Life Sciences Index, a study about perceptions of innovation and growth in the life sciences...
04 Jul, 2023 Updated telehealth guidelines to increase protection for patients By Greg Bodulovic Nicholas Tyacke Alex Horder Alexandra de Zwart Tudor Filaret Sharon Zhang +3 more... Show less The Medical Board of Australia (MBA) has issued updated guidelines for telehealth consultations between medical doctors and patients that...
20 Apr, 2023 Cross-border considerations for privacy in clinical trials - At the Intersection of Sciences and Law Podcast Series By James Clark Paula Gonzalez de Castejón Llano-Ponte David Kopans In this episode of At the Intersection of Sciences and Law Podcast Series, in light of the recent publication of our Cross-border Guide...
15 Nov, 2022 Clinical Trials and Privacy Matters: A Cross-border Guide By Marco de Morpurgo This week our Life Sciences team published the first edition of its Cross-border Guide to Clinical Trials and Privacy. The Guide will...
25 Jan, 2022 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include significant updates to several...
23 Nov, 2021 Is the UK the right home for life sciences startups? By Lyndsey Hudson I saw this recent article highlighting the need for the UK to create a much more supportive and sustainable environment for life sciences...
08 Nov, 2021 Telehealth and Australia's mental health care transformation By Matt Rozario Greg Bodulovic Alexandra Moore Australia continues to rapidly integrate telehealth as an accepted and much desired element of health care delivery, in particular within...
05 Oct, 2021 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include the additions of Sweden and...
25 May, 2021 Launch of DLA Piper Global COVID-19 Vaccine Guide for Employers By Pilar Menor Marco de Morpurgo As the scientific response to the COVID-19 pandemic develops, many employers are considering what their approach should be to the issues...
17 May, 2021 Interactions with healthcare professionals – launch of the new DLA Piper interactive compliance site for pharmaceutical companies By Marco de Morpurgo Andrzej Balicki, Ph.D. Ethical relations with healthcare professionals are of vital importance for pharmaceutical companies. Cooperation with them results in a...
23 Nov, 2020 Telehealth around the world: A global guide By Greg Bodulovic Marco de Morpurgo The COVID-19 pandemic has caused healthcare systems around the globe to rapidly, and in some cases, radically rethink the delivery of...
18 Sep, 2020 Digital Therapeutics - evolution and entry into mainstream healthcare By Marco de Morpurgo Research undertaken by DLA Piper's Life Sciences sector in conjunction with The Lawyer seeks to understand the current developments in...
23 Apr, 2020 Clinical trials during the COVID-19 pandemic: A global guide By Dr Kokularajah Paheenthararajah After weeks of intensive collaboration and inspiring contributions from more than 100 Life Sciences enthusiasts across five continents,...